We have demonstrated that ribosomal protein S19 (RP S19) polymer, when crosslinked between Lys122 and Gln137 by activated coagulation factor XIII, acts as a C5a receptor (C5aR) antagonist/agonist. Based on experimental data obtained using RP S19 analog peptide and recombinant protein monomer, we suggested that L 131 DR, I 134 AGQVAAAN and K 143 KH moieties in the RP S19 C-terminus act in, respectively, C5aR binding, penetration of the plasma membrane, and interaction with either an apoptosis-inducing molecule in neutrophils (delta lactoferrin) or a calcium channel-activating molecule (annexin A3) to induce the p38 MAPK pathway in macrophages. Recently, we observed RP S19 trimer in serum. To study the effects of this RP S19 trimer on C5aR, we prepared mutant RP S19 C-terminal peptide (RP S19 dimer and trimer, and examined their chemotactic activities and signal transduction pathways in human C5aR-overexpressing squamous cell carcinoma HSC-1 (HSC-1 C5aR ) cells using 24 trans-well chamber and western blotting assays, respectively. HSC-1 C5aR cells were attracted by RP S19 122-145 dimer and vice versa by RP S19 122-145 trimer. The RP S19 122-145 dimer-induced attraction was competitively blocked by pretreatment with RP S19 122-145 trimer. Moreover, RP S19 122-145 trimer-induced p38 MAPK phosphorylation was stronger than RP S19 122-145 dimer-induced p38 MAPK phosphorylation. RP S19 122-145 trimer appeared to act as a C5aR antagonist. The agonistic and antagonistic effects of RP S19 122-145 dimers and trimers were reflected by monocytic, THP-1-derived macrophage-like cells. Unlike the C5aR agonist C5a, which acts at the inflammation phase of acute inflammation, RP S19 trimer might act as a C5aR antagonist at the resolution phase.
Introduction
C5a is generally cleaved from C5 (a plasma protein released from hepatocytes) by C5 convertase at the inflammatory phase of acute inflammation [1] . The chemotactic potency of neutrophils is usually suppressed in C5-deficient acute inflammation mouse models [2] . Therefore, we believe that C5a functions as a neutrophil C5a receptor (C5aR) agonist to transmit a pro-inflammatory signal. Based on the NMR structure of C5a and experiments in which C5aR is mutated, the C5a C-terminus (L 72 GR) has been suggested to bind to C5aR-activating sites [3, 4] . When the GDP form of the Gαi2 subunit is exchanged with the GTP form of this subunit via the guanidine exchange factor activity of C5aR, the Gβγ subunits commonly interact with phospholipase Cβ2 in an intracellular calcium-dependent manner. After intracellular calcium is released, the calcium channel on the plasma membrane is activated (opened), thereby inducing cell motility through the signals of phosphatidylinositol 3-kinase and the extracellular signal-regulated protein kinases 1/2 (ERK1/2). The C5aR C-terminal phosphorylation that is downstream of the ERK1/2 pathway induces receptor internalization to restrict excessive neutrophil action. The C5aR gene is known not to have splice variant mRNAs [5] . However, excessive neutrophil activation is sometimes observed during the resolution phase in C5aR-deficient acute inflammation mouse models [6, 7] .
We purified S19 ribosomal protein (RP S19) polymer as a monocyte-specific chemoattractant in rheumatoid arthritis synovial tissue extracts [8] . In this case, RP S19 monomers in apoptotic cells are crosslinked between Lys122 and Gln137 due to the activation of tissue transglutaminases. Conversely, RP S19 monomers in plasma move to phosphatidylserine on platelets during acute inflammation and are crosslinked due to the activation of coagulation factor XIII [9] . Based on data obtained using mutated crosslinked RP S19 recombinant protein, the RP S19 dimer attracted monocytes/macrophages but not neutrophils [10] . Moreover, L 131 DR and I 134 AGQVAAANKKH moieties located in the RP S19 C-terminus functioned in C5aR binding and in antagonistic or agonistic switching, respectively. To examine the cell type-specific switching mechanism, we prepared the Gly73Asn mutant of C5a recombinant protein containing I 134 AGQVAAANKKH, C5a/RP S19. Interestingly, partner molecules to C5a/RP S19 include delta lactoferrin (δLf) in neutrophils and full-length annexin A3 (ANXA3) in macrophages [11, 12] . δLf is a transcription factor that induces apoptosis. Conversely, ANXA3 is an activator that opens calcium channels on the plasma membrane to transmit signals in the p38 mitogen-activated protein kinase (p38 MAPK) pathway. Therefore, we suggested that the RP S19 polymer functions as a cell-specific C5aR antagonist/agonist.
The RP S19 monomer in plasma and the corresponding polymer in serum were detected using anti-RP S19 rabbit IgGs [13] . Especially, RP S19 polymer was cross-reacted with anti-C5a rabbit IgGs. We recently observed a band at 50 kDa that reacted with both anti-RP S19 and anti-C5a rabbit IgGs using western blotting, as previously shown in guinea pig serum [14, 15] . To study the roles of the RP S19 trimer in serum, we newly prepared the mutant RP S19
122-145 peptide (RP S19 ) trimer and C5aR-overexpressing human squamous cell carcinoma HSC-1 (HSC-1
C5aR
) cells. The RP S19
122-145 trimer appeared to work as a C5aR antagonist through inducing a strong p38 MAPK signal. The RP S19 trimer most likely acts as a C5aR antagonist during the resolution phase of acute inflammation.
Materials and methods

Reagents
The RP S19 C-terminus (K 122 LTPQGQRDLDRIAGQVAAANKKH) peptide (the RP S19 122-145 monomer) was prepared using Fmoc-solid phase synthesis and an automated peptide synthesizer (Liberty Blue; CEM Corporation, NC, USA); Fmoc-NH-SAL resin was used to prepare the C-terminal amide, and H-His(Trt)-Trt(2-Cl) resin was used to prepare the C-terminal acid (Watanabe Chemical Ind., Hiroshima, Japan) (Fig. 1A ). The peptides were purified using reversed-phase high performance liquid chromatography (HPLC) and C18 columns (Nacalai tesque, Kyoto, Japan); the identity of the peptides was confirmed by mass spectrometry using Autoflex (Bruker Daltonics, MA, USA) or LCQDeca XP Plus (Thermo Scientific, MA, USA) instruments and quantitative amino acid analysis. The RP S19 122-145 dimer (linked by triazole) was prepared using Click chemistry (Fig. 1C ) [16] . Thus, the RP S19 122-145 trimer was linked by thioether and triazole bonds (Fig. 1D) . Ac-RP S19 122-145-Asp-Gly-Gly-Cys-NH2 was fluorescence-labeled at the C-terminal Cys residue as a thioether by reaction with Alexa Fluor 568 C5 (Invitrogen, CA, USA) (RP S19
122-145-Cysalkyl-Cy5 monomer) ( Fig. 2A) or as a disulfide by reaction with a reagent that was prepared by reacting Alexa Fluor 568 C5, NHS ester and 2-aminoethyl methanethiosulfonate (RP S19
122-145-CysSS-Cy5 monomer) (Fig. 2B ).
Vector and HSC-1 cells
To generate HSC-1 transformed cells, pCMV6-C5aR1-GFP cDNA (NM_001736) (OriGene Technology, Inc. MD, USA) was cleaved using EcoRI restriction enzyme (TAKARA, Kyoto, Japan) and transferred into HSC-1 cells (RIKEN BioResource Center, Tukuba, Japan) using a NAPA21 electroplater (Nepa Gene Co., Ltd. were sorted using a BD FACSAria™III Cell Sorter (BD bioscience, Tokyo, Japan). The optimal clone was selected based on growth rate and sensitivity to the RP S19 122-145 monomer. Morphological changes of HSC-1 C5aR cells were usually observed using a Ti-E immunofluorescence microscope (Nikon, Tokyo, Japan). For analyses of Cy5 localization, HSC-1 C5aR cells were observed using an Axiovert/LSM510 instrument (Carl Zeiss, North Ryde, Australia).
Chemotaxis assay
HSC-1 C5aR cells (4 Â 10 5 cells/mL) were prepared in DMEM medium containing 10% FBS and 100 U penicillin/streptomycin for a chemotaxis assay in a 24-well trans-well chamber [17] . 1 Â 10 5 indicator cells in 250 mL and 10 À 6 M chemoattractants in 1 mL of the same cell culture medium were applied to the upper chamber equipped with an 8-mm pore filter and the lower chamber, respectively. First, 1 Â 10 5 monocytic THP-1 cells (RIKEN BioResource Center, Tsukuba, Japan) in 250 mL of the cell culture medium containing 100 nM phorbol 12-myristate 13-acetate (PMA) (the cell differentiation medium) and 1 mL of the same differentiation medium were applied to the upper and lower chambers, respectively. After one day, the cell differentiation medium in the lower or upper chambers was changed to the cell culture medium with or without 10 À 6 M of chemoattractants.
After 6 h of culture in an incubator under 5% CO 2 at 37°C with 85% humidity, the number of cells that migrated from the upper chamber to the lower chamber was counted using the trypan-blue dye exclusion method; at least 3 wells were counted in each of 4 different experiments.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis and Western blotting
Total proteins of HSC-1 C5aR cells were suspended in lysis buffer (7 M urea, 2 M thiourea, 1% Triton X-100, 18 mM dithiothreitol, and 0.1% bromothymol blue) and applied to 12% SDS-polyacrylamide gel electrophoresis gels. The proteins were electrophoretically transferred to an Immobilon Transfer Membrane™ (Millipore, MA, USA) using a semi-dry electroblotter (Sartorius, Göttingen, BRD) for 90 min using a current of 15 V. Phosphorylated and nonphosphorylated anti-p38 MAPK or anti-ERK1/2 rabbit IgGs were obtained from Cell Signaling Technology (MA, USA). Primary antibodies (200 ng/mL) were incubated for 1 h at 22°C, and HRPconjugated anti-rabbit IgGs goat IgGs secondary antibody (20 ng/mL; Santa Cruz Biotechnology, CA, USA) was incubated for 30 min at 22°C. The signals were detected using the ECL-Plus Western Blotting Detection System™ (GE Healthcare, Tokyo, Japan). The phosphorylation ratio of p38 MAPK to ERK1/2 was calculated based on the non-phosphorylated band densities in Western blots using ImageJ 1.46 (National Institutes of Health, MD, USA).
Statistical analysis
Each result was confirmed in multiple experiments using a minimum of three samples. Statistical significance was calculated by non-parametric and parametric tests with two-way analysis of variance. The values are presented as the means 7SD. A Pvalue o0.05 was considered statistically significant, and the results are presented as P o0.05 (*) or P o0.01 (**).
Results and discussion
The roles of the RP S19 C-terminus in C5aR
RP S19 recombinant protein monomers were crosslinked due to the activation of coagulation factor XIII, and at least 4 kinds of fractions were collected by HPLC using a C4 column. The main components in fractions 1-4 were identified using sodium dodecyl sulfate polyacrylamide gel electrophoresis as the intra-crosslinked monomer and the inter-crosslinked dimer, tetramer and hexamer, respectively [18] . The purity of each fraction was at least 50%. The chemotactic activity against monocytes/macrophages was slightly increased and that against neutrophils was not observed by any fractions. Moreover, the antagonistic/agonistic dual functions of the RP S19 polymer were reflected by both C5a/RP S19 recombinant protein and analog peptide monomers. We recently showed that RP S19 C-terminus includes three regions: the C5aR binding region (L 131 DR), the membrane-penetrating region (I 134 AGQVAAAN), and the antagonist/agonist switching region (K 143 KH) [19, 20] . Therefore, we suggested that the RP S19 122-145-Cysalkyl-Cy5 monomer C-terminus was mainly observed on the cytoplasmic side of the plasma membrane. This localization did not change until at least 30 min after stimulation. These data reflected a lack of C5aR internalization after the stimulation with C5a/RP S19 through the p38 MAPK pathway [21] . At 5 min after stimulation, the RP S19 122-145-CysSS-Cy5 monomer C-terminus was also mainly observed at the cytoplasmic side of the plasma membrane. However, the RP S19 122-145-CysSS-Cy5 monomer C-terminus moved to the cytoplasmic side at 30 min after the stimulation. Thus, -S-Cy5 in RP S19 monomer in a trans-well chamber (Fig. 3) . At 6 h after the stimulation, HSC-1 C5aR cells in the upper chamber significantly migrated into the lower chamber containing the RP S19
122-145-Cysalkyl-Cy5 monomer or the RP S19
122-145-CysSS-Cy5 monomer to a greater extent than HSC-1 cells. These data indicated that the -Cysalkyl-Cy5 modification but not the -CysSSCy5 modification to the K 143 KH moiety of the RP S19 monomer affected the complex with ANXA3 to induce chemotaxis through the p38 MAPK pathway.
The roles of the RP S19 122-145 trimer in C5aR
To examine the roles of the RP S19 122-145 trimer in C5aR, HSC-1 cells or HSC-1 C5aR cells were stimulated with the monomer, the dimer or the trimer (see Fig. 1A , C, and D) in a trans-well chamber (Fig. 4A) . At 6 h after the stimulation, the number of HSC-1 cells that migrated into the chamber containing any RP S19 peptides was significantly lower than the number of HSC-1 C5aR cells that migrated. When using vehicle buffer, no significant difference was observed. C5aR was specifically activated by RP S19 122-145 peptides. Interestingly, the chemotactic activity of the RP S19 dimer or trimer was the highest or lowest among the RP S19 peptides. The chemotactic activity of the RP S19 122-145 trimer was significantly higher than that of vehicle buffer.
To confirm the structure of the RP S19 122-145 trimer, 1 Â 10 5 HSC-1 C5aR cells were mixed with 10 À 6 M RP S19 122-145 trimer or vehicle buffer for 5 min These mixtures and 10 À 6 M RP S19 dimer or trimer were applied to the upper and lower chambers, respectively (Fig. 4B) . After 6 h of incubation, the number of HSC-1 C5aR cells that migrated into the chamber containing the RP S19 122-145 dimer was significantly decreased when pre-treated with the RP S19 122-145 trimer.
To study the sensitivity of the RP S19 122-145 trimer to the C5aR-mediated p38 MAPK signal in HSC-1 C5aR cells, 1 Â 10 6 cells were seeded on a Φ100 mm cell culture dish (Fig. 4C) . After one day, 10 À 6 M of the monomer, dimer or trimer were mixed with culture medium for 20 min, and proteins in the attached cells were collected for Western blotting. p38 MAPK phosphorylation was highest and lowest in HSC-1 C5aR cells after stimulation with the RP S19 122-145 trimer and vehicle buffer. Conversely, ERK1/2 phosphorylation was highest and lowest in HSC-1 C5aR cells after stimulation with vehicle buffer and the RP S19 122-145 trimer. ERK1/2 phosphorylation was most likely detected via constitutively activated GPCRs. The p38 MAPK/ERK1/2 phosphorylation ratio appeared to change from antagonist to agonist (Fig. 4D) Interestingly, several reports indicate that the migration of glioma cells in response to lysophosphatidic acid is partially inhibited by the activation of the p38 MAPK pathway in response to the down-regulation of cdc-42 [22] . Conversely, the p38 MAPKenhanced invasion of colon cancer Caco-2 and HT29cells is inhibited in response to the down-regulation of MMP-9 [23] . Also interestingly, reports indicate that the p38 MAPK signal appears to promote apoptosis in bladder carcinoma cells or cancer stem cells, as previously shown by us in apoptotic cells, including neutrophils [24, 25] .
The roles of the GPCR agonist trimer
Based on solution NMR and x-ray crystallography data, CXC and CC chemokines are believed to work mainly during the inflammatory phase of acute inflammation as a monomer. However, N-terminal cysteines are believed to have strong dimerization potential [26] . Experimentally, dimerization is sensitive to solution conditions, such as low pH and long ionic strength. When CCL2 and CCL4 were experimentally linked by disulfide bonds, the dimer did not bind to their receptors. Conversely, the CXCL8 dimer bound to another receptor, CXCR2 [27, 28] . We recommend that all chemokine researchers attempt to purify chemokine polymers in biomaterials. We strongly suggest that a crosslinked chemokine that is polymerized by factor XIIIa is present in serum.
As shown in Fig. 5 , we confirmed the agonistic and antagonistic dual effects on macrophage-like THP-1 cells. THP-1 cells do not generally express δLf, which means that three p38 MAPK signals are transmitted via three K 143 KH moieties through three ANXA3s (see Graphical Abstract). The strong p38 MAPK signals might connect directly to unknown antagonistic pathways.
Conversely, chemokine polymer research also suggests that these CXC and CC chemokines play a role in cancer metastasis. When CXCL12 monomer binds to CXCR4, Gs protein-dependent inhibition of cAMP signaling promotes metastasis [29] . In the case of the CXCL12 dimer, CXCR4 also promotes metastasis through another signal transduction pathway via the weak phosphorylation of ERK1/2. In addition, ligand-independent polymerization endows CXCR4 with an enhanced affinity for CXCL12 [30] . We need to further examine the roles of ligand-dependent polymerization. trimer in a trans-well chamber assay (n¼ 4).
